Deal Street

2024 African Venture Capital Report

Coming Soon

African Startup Funding Tracker

US$741,804,000+

*Data updated daily at 18:00 EAT

MYDAWA Bags New Investment To Drive AI-Enabled Health Expansion In East Africa
MYDAWA Bags New Investment To Drive AI-Enabled Health Expansion In East Africa

MYDAWA, a digital health platform that took off in Kenya, has secured a fresh funding round from a consortium of top global healthcare investors to accelerate its regional expansion and technological capabilities.

While the amount remains undisclosed, the round was led by IFU, Alta Semper, AAIC Investment, Creadev and Japan-based Ohara Pharmaceutical Co., a group known for backing transformative health ventures across both emerging and developed markets.

Founded in 2017, MYDAWA offers an integrated, end-to-end health platform spanning online doctor consultations, e-prescriptions, lab tests, chronic care management and last-mile delivery.

With operations in Kenya and Uganda, the company has become a key player in addressing East Africa’s healthcare access gaps, particularly persistent challenges around affordability, stock availability and delivery delays.

This new investment will help MYDAWA scale its “bricks-and-clicks” pharmacy model, expand its chronic care programmes, and incorporate AI features to improve supply chain efficiency and service delivery.

The company has already enrolled more than 5,000 chronic care patients and served over 1.8 million people in 2024 alone. Recent strategic moves, including the acquisition of Uganda’s Rocket Health, signal a broader regional push. Previously, in 2023, MYDAWA raised USD 20 M and acquired Uganda’s Guardian Health.

Investor confidence appears to stem from MYDAWA’s solid traction and product-market fit, with revenue reportedly growing over 30% year-on-year and a relatively low customer acquisition cost. MYDAWA also benefits from key partnerships with hospitals, insurers, pharmaceutical firms like Novo Nordisk, and major donors such as the Gates Foundation, which funds its PrEP and PEP programmes currently serving over 3,000 patients.

With this new backing, MYDAWA is positioning itself not merely as a service provider, but as a regional blueprint for the future of healthcare delivery, one that blends tech-driven convenience with real-world reach.